Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Substance P in Recent-Onset Type 1 Diabetes
NCT02820558Phase 1Unknown
- Sponsor
- Vanilloid Genetics Inc.
- Start
- May 2016
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 1, open-label trial of substance p in type 1 diabetes mellitus (T1D) (4 arms), sponsored by Vanilloid Genetics Inc. Primary endpoint: Stage A Safety: Side effects reported for entire cohort. Status: unknown.
02
Drugs
substance p
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02820558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02820558.